CCTAP: Cognitive Control Training for Treatment of AUD-PTSD
|ClinicalTrials.gov Identifier: NCT03200028|
Recruitment Status : Completed
First Posted : June 27, 2017
Last Update Posted : October 15, 2019
|Condition or disease||Intervention/treatment||Phase|
|Alcohol Use Disorder Post Traumatic Stress Disorder||Other: Computerized Plasticity-Based Adaptive Cognitive Training||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||9 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||CCTAP: Cognitive Control Training for Treatment of AUD-PTSD|
|Actual Study Start Date :||April 1, 2018|
|Actual Primary Completion Date :||February 28, 2019|
|Actual Study Completion Date :||February 28, 2019|
Experimental: Experimental Treatment
Computerized plasticity-based adaptive cognitive training requiring a total maximum of 30 treatment sessions, up to 5 sessions per week, 30 minutes per session.
Other: Computerized Plasticity-Based Adaptive Cognitive Training
Thirty minutes of training on computerized exercises that targets executive function, memory and attention.
- Acceptability [ Time Frame: At 6 weeks ]Acceptability will be evaluated through Cognitive Training Acceptability Measure. This measure is comprised of 17 statements about their training experience and participants will be asked to rate each statement on a 7-point Likert scale from Strongly Disagree to Strongly Agree.
- Usability [ Time Frame: At 6 weeks ]Usability will be evaluated through the Computer System Usability Questionnaire and System Usability Scale. The Computer System Usability Questionnaire and System Usability Scale is comprised of a total of 29 statements and participants will be asked to rate the usability of the system on a 7-point Likert scale from Strongly Disagree to Strongly Agree.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03200028
|United States, California|
|Veterans Affairs Palo Alto Health Care System|
|Palo Alto, California, United States, 94025|
|Principal Investigator:||Hyun Kyu Lee, PhD||Posit Science Corporation|